Pancreatic ductal adenocarcinoma (PDAC) is the most common (90%) type of solid
pancreatic neoplasm. Due to its late presentation and poor survival rate, early diagnosis and …

Pancreatic ductal adenocarcinoma (PDAC) is aggressive and lethal with the majority of
cases presenting with advanced unresectable disease due to delayed diagnosis. Despite …

Since the introduction of endoscopic ultrasound guided fine-needle aspiration (EUS-FNA),
EUS has assumed a growing role in the diagnosis and management of pancreatic ductal …

Endoscopic ultrasound (EUS) has emerged as an invaluable tool for the diagnosis, staging
and treatment of pancreatic ductal adenocarcinoma (PDAC). EUS is currently the most …

Endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) currently plays a central role in
the diagnosis of pancreatic ductal adenocarcinoma (PDAC). Although fine‐needle …

Endoscopic ultrasound (EUS) is a technique that combines the potential of endoscopy,
which enables the visual examination of the mucosal surface of any gastrointestinal (GI) …

With recent advances in molecular pathology and the development of new chemotherapy
regimens, the knowledge of the molecular alterations of pancreatic ductal adenocarcinoma …

Pancreatic cancer is one of the leading causes of cancer-related mortality in western
countries. Early diagnosis of pancreatic cancers plays a key role in the management by …

Introduction: Cross sectional imaging is important for initial evaluation of pancreatic cancer,
whereas endoscopic ultrasound (EUS) will often help better visualize, differentiate and make …

Pancreatic cancer (PC) is the fourth most common cause of cancer deaths in Western
societies. It is an aggressive tumor with an overall 5-year survival rate of less than 5 …